Adma Biologics Inc Earnings

Adma Biologics Inc’s revenue jumped 13.8% since last year same period to $121.98Mn in the Q2 2025. On a quarterly growth basis, Adma Biologics Inc has generated 6.26% jump in its revenue since last 3-months.

Adma Biologics Inc’s net profit jumped 6.73% since last year same period to $34.22Mn in the Q2 2025. On a quarterly growth basis, Adma Biologics Inc has generated 27.19% jump in its net profits since last 3-months.

Adma Biologics Inc’s net profit margin fell -6.22% since last year same period to 28.05% in the Q2 2025. On a quarterly growth basis, Adma Biologics Inc has generated 19.7% jump in its net profit margins since last 3-months.

Adma Biologics Inc’s price-to-earnings ratio after this Q2 2025 earnings stands at 20.12.

Adma Biologics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.17 - a 11.13% jump from last quarter’s estimates.

Adma Biologics Inc’s earning per share (EPS) estimates for the current year stand at 0.17.

Adma Biologics Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Adma Biologics Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.